Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy (Q91256518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

main subject

neoplastic stem cells

1 reference

Gregg L Semenza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Lisha Xiang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

publication date

19 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

Advances in Cancer Research

20 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

175-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

20 April 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1371/JOURNAL.PONE.0006146

Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional TargetsCyr61andCTGF

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Mammalian homologs of seven in absentia regulate DCC via the ubiquitin–proteasome pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Aging: a theory based on free radical and radiation chemistry

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The methylation state of poly A-containing-messenger RNA from cultured hamster cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Histone demethylase JMJD2C: epigenetic regulators in tumors.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factor 1 and cardiovascular disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

N6-methyladenosine-dependent regulation of messenger RNA stability

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Biology of hypoxia-inducible factor-2alpha in development and disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self-renewal and early development

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Heterogeneity in breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Significance of interleukin-6 (IL-6) in breast cancer (review).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

MAP kinase phosphatases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Metabolic regulation of redox status in stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

2i Maintains a Naive Ground State in ESCs through Two Distinct Epigenetic Mechanisms

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The Hippo Signaling Pathway in Development and Cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Radical causes of cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Gene expression regulation mediated through reversible m⁶A RNA methylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

DUSPs, to MAP kinases and beyond.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Emerging roles of TEAD transcription factors and its coactivators in cancers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-Inducible Factors: Master Regulators of Cancer Progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Filling out the Hippo pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HypoxamiRs and cancer: from biology to targeted therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CoREST is an integral component of the CoREST- human histone deacetylase complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Glutathione S-conjugates as prodrugs to target drug-resistant tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Identification, characterization, and crystal structure of the Omega class glutathione transferases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HIF induces human embryonic stem cell markers in cancer cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1α (HIF-1α)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF-1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Metastatic stem cells: sources, niches, and vital pathways

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Emerging roles of RNA modification: m(6)A and U-tail

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Histological and molecular types of breast cancer: is there a unifying taxonomy?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hes1: a key role in stemness, metastasis and multidrug resistance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Mitochondria, oxidants, and aging

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

REST is a hypoxia-responsive transcriptional repressor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP)

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Coordinated histone modifications mediated by a CtBP co-repressor complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Structure and regulation of MAPK phosphatases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia--a key regulatory factor in tumour growth

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Integrin-associated protein (CD47) and its ligands

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Tumor cells upregulate normoxic HIF-1α in response to doxorubicin

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Applying the principles of stem-cell biology to cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Addendum: A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Nomenclature for mammalian soluble glutathione transferases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Yeast targets for mRNA methylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The pharmacology of intracellular Ca(2+)-release channels

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factor 3 biology: complexities and emerging themes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Sox2 expression in breast tumours and activation in breast cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Emerging role of nanog in tumorigenesis and cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Triple-Negative Breast Cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell-Like Behaviors in Hepatocellular Carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Evolution of C2H2-zinc finger genes and subfamilies in mammals: species-specific duplication and loss of clusters, genes and effector domains

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Sequence specificity of the human mRNA N6-adenosine methylase in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Metabolic regulation of hematopoietic stem cells in the hypoxic niche

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Implications of Hypoxia in Breast Cancer Metastasis to Bone

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The regulation of transcriptional repression in hypoxia.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Regulation of MAP kinases by MAP kinase phosphatases.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Programmed cell removal: a new obstacle in the road to developing cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Signal transduction by the JNK group of MAP kinases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Role of CD47 as a marker of self on red blood cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Histone methylase MLL1 coordinates with HIF and regulate lncRNA HOTAIR expression under hypoxia.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Prospective identification of tumorigenic breast cancer cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Tissue distribution of drug-metabolizing enzymes in humans

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Sprouts of RNA epigenetics: the discovery of mammalian RNA demethylases.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Regulation of TAZ in cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Cancer stem cells: in the line of fire

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Effects of age and macrophage lineage on intracellular survival and cytokine induction after infection with Rhodococcus equi

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Mitogen-activated protein kinases in apoptosis regulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Immunology. Making macrophages eat cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The ZNF217 oncogene is a candidate organizer of repressive histone modifiers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Comprehensive Genome Sequence Analysis of a Breast Cancer Amplicon

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The biology of chemokines and their receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Mammalian MAP kinase signalling cascades

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The cancer stem cell: premises, promises and challenges

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia inducible factors in cancer stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Cancer stem cells and their role in metastasis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Detection and characterization of tumor hypoxia using pO2 histography

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/BS.ACR.2018.11.001

Identifiers

DOI

10.1016/BS.ACR.2018.11.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30691683%20AND%20SRC:MED&resulttype=core&format=json